The significance of cytomegalovirus viremia at day 100 or more following allogeneic hematopoietic stem cell transplantation.

about

Synthetic DNA approach to cytomegalovirus vaccine/immune therapy

P2860

Q36069582-A59B44AE-32AD-4067-B8BC-B3760543066F

P2860

The significance of cytomegalovirus viremia at day 100 or more following allogeneic hematopoietic stem cell transplantation.

Item

http://www.wikidata.org/entity/Q38102060

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The significance of cytomegalo ...... tic stem cell transplantation.

@en

type

Item

label

The significance of cytomegalo ...... tic stem cell transplantation.

@en

prefLabel

The significance of cytomegalo ...... tic stem cell transplantation.

@en

P1476

The significance of cytomegalo ...... etic stem cell transplantation

@en

P2093

Catherine Lai

http://www.w3.org/2001/XMLSchema#string

David Peace

http://www.w3.org/2001/XMLSchema#string

Jennifer E Layden

http://www.w3.org/2001/XMLSchema#string

Julie Rowe

http://www.w3.org/2001/XMLSchema#string

Karen Sweiss

http://www.w3.org/2001/XMLSchema#string

Shellee A Grim

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the intensity of conditioning regimens: working definitions

Definitions of cytomegalovirus infection and disease in transplant recipients

Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study.

Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.

Extended antigenemia surveillance and late cytomegalovirus infection after allogeneic BMT.

High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection.

Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia.

Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation.

Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT.

Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation.

P304

510-516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CTR.12128

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nina Clark

P577

2013-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23621704

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

The significance of cytomegalovirus viremia at day 100 or more following allogeneic hematopoietic stem cell transplantation.

about

P2860

P2860

The significance of cytomegalovirus viremia at day 100 or more following allogeneic hematopoietic stem cell transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921